A detailed history of Advisor Net Financial, Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Advisor Net Financial, Inc holds 22 shares of NBIX stock, worth $2,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$2,727
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$130.4 - $143.74 $782 - $862
-6 Reduced 21.43%
22 $3,000
Q4 2023

Jan 19, 2024

BUY
$106.07 - $132.76 $2,545 - $3,186
24 Added 600.0%
28 $3,000
Q2 2023

Jul 14, 2023

BUY
$89.53 - $104.87 $89 - $104
1 Added 33.33%
4 $0
Q1 2023

Apr 28, 2023

BUY
$94.11 - $123.02 $94 - $123
1 Added 50.0%
3 $0
Q4 2022

Jan 13, 2023

BUY
$106.72 - $127.06 $213 - $254
2 New
2 $0

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.